Now in its 17th year, this two-day symposium has been planned for the providers who care for patients with rheumatic disease. Given the wide variety of rheumatologic disorders, and an ever increasing number of diagnostic procedures and treatment options, it is necessary to provide clinicians with information about strategies for the early diagnosis of these conditions, novel state-of-the-art diagnostic tools, and opportunities to utilize the most effective treatments to ensure optimal patient outcomes.
Dates
Streamed Live on May 7-8, 2021
Accreditation Statement
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Johns Hopkins University School of Medicine designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Credits
- American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
- American Association of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
- National Commission on Certification of Physician Assistants (NCCPA) PAs may claim a maximum of 14.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
- The Johns Hopkins University has approved this activity for 14.50 contact hours for non-physicians.
Policy on Presenter and Provider Disclosure
It is the policy of the Johns Hopkins School of Medicine that the presenter and provider globally disclose conflicts of interest. The Johns Hopkins School of Medicine OCME has established policies that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.
| NAME | ROLE | RELATIONSHIPS |
| Antoine Azar, MD | Presenter | Consulting Fee: Grifols and Horizon Contracted Research/Principal Investigator: Grifols, X4 |
| Alan Baer, MD | Presenter | Royalty-UpToDate/Consulting Fee: Bristol-Myers Squibb |
| Clifton Bingham, MD | Activity Director | Consulting Fee: AbbVie, Bristol-Myers Squibb, Eli Lilly and Company, Genentech, Gilead, Janssen, Pfizer Inc., Regeneron/Sanofi, and Walgreens Contracted Research: Bristol-Myers Squibb Principal Investigator: Eli Lilly and Company, Genentech, Inc, Kolon/Tissue Gene, Pfizer, Inc. Regeneron/Sanofi, Pfizer, Inc and Walgreens |
| Laura Cappelli, MD, MHS | Presenter | Contracted Research/Principal Investigator: AbbVie and Bristol-Myers Squibb Consulting Fee: AbbVie |
| Chad Deal, MD | Presenter | Speakers Bureau: Alexion, Amgen and Radius, *Lecture not for CME credit* |
| Atul Deodhar, MD | Presenter | Consulting Fee: AbbVie, Amgen, Boehringer Ingelheim Vetmedica GmbH, Bristol-Myers Squibb, Eli Lilly and Company, Janssen, Novartis AG, Pfizer, and UCB Principal Investigator: AbbVie, Janssen, Pfizer, Inc., and UCB Research Grant: Amgen, Boehringer Ingelheim Vetmedica GmbH, Bristol-Myers Squibb, and Novartis AG |
| Laura Hummers, MD | Presenter | Contracted Research: Boehringer Ingelheim Vetmedica GmbH, Corbus Pharmaceuticals, Cumberland, Kadmon Pharmaceuticals and Medpace, Inc Principal Investigator: Boehringer Ingelheim Vetmedica GmbH, CSL Behring, Kadmon Pharmaceuticals and Medpace, Inc Consulting Fee: Abbvie, Boehringer Ingelheim Vetmedica GmbH, Corbus Pharmaceuticals and CSL Behring |
| Maximillian Konig, MD | Presenter | Consulting Fee: Celltrion and Third Bridge |
| Tuhina Neogi, MD | Presenter | Consulting Fee: EMD Serono, Flexion, Novartis AG, Pfizer, Inc. and Regeneron |
| Ana-Maria Orbai, MD, MHS | Presenter | Contracted Research: AbbVie, Amgen, Celgene Inc, Principal Investigator: AbbVie and Amgen, Consulting Fee: Janssen and Novartis AG |
| Michelle Petri, MD | Presenter | Contracted Research: Alexion, AstraZeneca, Gilead, GlaxoSmithKline, Eli Lilly and Company, Exagen, Idorsia Pharmaceuticals, Johnson & Johnson and Thermofisher, Principal Investigator: EMD Serono Consulting Fee: Amgen, Aurinia, AstraZeneca, Boston Pharmaceuticals, Eli Lilly and Company, EMD Serono, Emergent Biosolutions, Exagen, GlaxoSmithKline, Johnson and Johnson, Kezar Life Sciences, UCB Pharmaceuticals and IQVIA Honoraria: Sanofi-Aventis, Momenta Pharmaceuticals, Inc., PPD Development and Thermofisher |
| Victoria Ruffing, RN-BC | Co-Director | Consulting Fee: Abbott Laboratories and Sanofi-Aventis |
| John Stone, MD, MPH | Presenter | Consulting Fee: Bristol-Myers Squibb, Horizon, and Roche Principal Investigator: Bristol-Myers and Sanofi Aventis |
American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) Program
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 14.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
POST-TEST
To receive MOC Credit, a post-test will be conducted at the conclusion of the activity. A grade of at least 75% within three attempts is needed to receive CME credit. The post test is not required if you do not need MOC.
HOW TO OBTAIN CME CREDIT
Post activity, an online evaluation will be available to attendees to evaluate the activity and individual presentations and to identify future educational needs. Upon completion of the evaluation, the learner must attest to the number of hours in attendance. Credits earned will be added to the learner’s transcript and immediately available for print. For ABIM credit, a post test is also required and can be found in the same location as the evaluation. The last day to access the evaluation and post-test and to attest to your credits is June 22, 2021.
Johns Hopkins Statement of Responsibility
The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.
Copyright
All rights reserved – The Johns Hopkins School of Medicine. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.
Internet CME Policy
The Office of Continuing Medical Education (OCME) at the Johns Hopkins School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins School of Medicine OCME maintains its internet site as an information resource and service for physicians, other health professionals and the public. OCME at the Johns Hopkins School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins School of Medicine CME program. CME collects only the information necessary to provide you with the services that you request.
Disclaimer Statement
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This activity is produced for educational purposes only. Use of Johns Hopkins School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
HARDWARE/SOFTWARE REQUIREMENTS
Internet connection.
AMERICANS WITH DISABILITIES ACT
The Johns Hopkins School of Medicine fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.
ACKNOWLEDGEMENTS
We wish to acknowledge the following companies that have provided or pledged an educational grant in support of this activity. Please note that commercial support received is solely for the educational component of the activity and will not be used to provide food and beverage.
- AbbVie
- Bristol-Myers Squibb
- Janssen Scientific Affairs, LLC
- Novartis Pharmaceuticals Corporation
EXHIBITORS
- AbbVie
- Amgen
- Aurinia
- Bristol-Meyers Squibb
- Boehringer Ingelheim Pharmaceuticals, Inc.
- GlaxoSmithKline
- Janssen Biotech
- Novartis Pharmaceuticals, Inc. –Iilaris
- UCB
Late Fee and Refund Policy
A $25 late fee applies to registrations received after 5:00 p.m. ET on March 28, 2020. A handling fee of $25 will be deducted for cancellation. Refund requests must be received by fax or mail by May 1, 2021. No refunds will be made thereafter. Transfer of registration to another Johns Hopkins activity in lieu of cancellation is not possible.